Mosaic ImmunoEngineering, Inc. (CPMV)
OTCMKTS · Delayed Price · Currency is USD
0.7450
0.00 (0.00%)
Apr 7, 2026, 4:00 PM EST
Mosaic ImmunoEngineering Market Cap
Mosaic ImmunoEngineering has a market cap or net worth of $5.4 million as of April 8, 2026. Its market cap has increased by 35.45% in one year.
Market Cap
5.40M
Enterprise Value
7.01M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.75
Market Cap Chart
Since October 15, 2020, Mosaic ImmunoEngineering's market cap has increased from 1.69M to 5.40M, an increase of 220.04%. That is a compound annual growth rate of 23.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 5.40M | 139.55% |
| Dec 31, 2025 | 2.25M | -55.65% |
| Dec 31, 2024 | 5.08M | 16.87% |
| Dec 29, 2023 | 4.35M | -39.39% |
| Dec 30, 2022 | 7.17M | -2.75% |
| Dec 31, 2021 | 7.37M | 181.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BetterLife Pharma | 7.92M |
| NKGen Biotech | 7.84M |
| Synlogic | 7.49M |
| Curative Biotechnology | 7.15M |
| Nymox Pharmaceutical | 6.22M |
| Orgenesis | 5.88M |
| AccuStem Sciences | 5.54M |
| Bioxytran | 5.00M |